Patent · US Expired

AAV vector compositions and methods for enhanced expression of immunoglobulins using the same

US7714119B2 · kind B2 · utility

10Cited by
31References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2005
Grant dateMay 11, 2010
Priority date
Expiry dateJul 13, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Single AAV vector constructs for expression of an immunoglobulin molecule or fragment thereof and methods of making and using the same are described. The AAV vectors comprise a self-processing cleavage sequence between a first and second immunoglobulin coding sequence allowing for expression of a functional antibody molecule using a single promoter. The vector constructs may further include an additional proteolytic cleavage sequence which provides a means to remove the self processing peptide sequence from an expressed immunoglobulin molecule or fragment thereof. The vector constructs find utility in enhanced production of biologically active immunoglobulins or fragments thereof in vitro and in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.